Eli Lilly Signs Research Deal With AI-Focused Genetic Leap

(Reuters) - Eli Lilly has entered into a research deal with artificial intelligence-focused firm Genetic Leap for up to $409 million to develop...

(Reuters) - Eli Lilly has entered into a research deal with artificial intelligence-focused firm Genetic Leap for up to $409 million to develop...